Text Size: A+| A-| A   |   Text Only Site   |   Accessibility
DHS logo
Oregon PRAMS: Presentations

Prevention of Birth Defects: Periconceptional Multivitamins
with Folic Acid (MVF)


Introduction | Background | Methods | Results | Discussion 1 | Discussion 2 | Discussion 3


Introduction:


Prevention of Birth Defects: Periconceptional
Multivitamins with Folic Acid (MVF)


Jill Moore (1)
Ken Rosenberg, MD, MPH (1,2)
Al Sandoval, MS, MBA (2)

(1) Oregon Health & Science University, Portland, Oregon
(2) Department of Human Services, Office of Family Health, Portland, Oregon

Seventh Annual MCH Epidemiology Conference
December 12, 2001
Clearwater Beach, Florida


Background:

  • 4000 NTD-affected pregnancies per year in United States
  • Folic Acid: prevents at least 50% of NTDs
  • All fertile women: 400Fg (0.4 mg) of folic acid/day supplement
  • Food folate is insufficient
  • Fortification of grains provides an average of 100Fg of folic acid/day


Methods:

  • Oregon PRAMS, 1998-99
  • Question: "Were you taking the vitamin folic acid most days
    in the month before you became pregnant?"
  • n = 1867/2855 women
  • Response Rate = 65.4%


Results:


 • Took periconceptional folic acid: 29.7%
 • Knew that folic acid use can prevent birth defects: 77.1%

 • Multivariate Risk Factors (for taking FA) Odds Ratio (95% CI)
 • Knowing that folic acid use can prevent birth defects ¶ 8.30 (3.45, 20.0)
 • Intended pregnancy * 3.70 (2.33, 5.88)
 • Having medical insurance † 2.13 (1.19, 3.70)
 • Family Income >= $30,000/yr § 1.85 (1.11, 3.13)
 • Not enrolled in WIC during pregnancy ± 1.67 (1.00, 2.78)
  • ¶ compared to not knowing that folic acid use can prevent birth defects
  • * compared to unintended pregnancy
  • † any health insurance compared to no insurance prior to pregnancy.
  • § annual family income before pregnancy, comparing to <$30,000/yr
  • ± compared to enrolled in WIC during pregnancy


Discussion 1:

  • Folic Acid prevents many Birth Defects, not just NTDs.


Discussion 2:

 • Czeizel, American Journal of Medical Genetics 1996;62:179-183
 • Intervention: 800mg Folic Acid + Multivitamins
 • Control: placebo ("trace elements")
 • n= 4862

  Intervention       Controls
 • Neural Tube Defects 0       6
 • After exclusion of these 6 NTDs:          
      • Major Birth Defects (MBD) 20.6       40.6
          per 1000 pregnancies          

 • Relative Risk of MBD for intervention group
                (compared to controls):
         •    RR= 0.54 (95% CI 0.39, 0.76)
                p= 0.0003


Discussion 3:

  • Women should be advised to take "Multivitamins with Folic Acid" rather than "Folic Acid"


Return to the top of the page.

 
Page updated: September 22, 2007

Click here to go to the Oregon Dept. of Veterans' Affairs outreach contact form

Get Adobe Acrobat ReaderAdobe Reader is required to view PDF files. Click the "Get Adobe Reader" image to get a free download of the reader from Adobe.